Home
/
HealthLynked Corp
/
Financials
/
Quarterly
HealthLynked Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HealthLynked Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$590.1K
Nov 14, 2024
Q2
2024
Jun 30, 2024
$795.1K
Aug 14, 2024
Q1
2024
Mar 31, 2024
$1.00M
May 15, 2024
Q3
2024
Sep 30, 2023
$1.33M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$1.70M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$1.76M
May 15, 2024
Q3
2023
Sep 30, 2022
$1.36M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$1.56M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$1.53M
May 15, 2023
Q3
2022
Sep 30, 2021
$4.04M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$1.71M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$1.78M
May 16, 2022
Q3
2021
Sep 30, 2020
$2.04M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$1.16M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$1.34M
May 17, 2021
Q3
2020
Sep 30, 2019
$1.17M
Nov 16, 2020
Q2
2020
Jun 30, 2019
$1.21M
Aug 14, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2023
Jun 30, 2023
$35.5K
Aug 14, 2023
Q1
2023
Mar 31, 2023
$16.3K
May 15, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($851.8K)
Nov 19, 2025
Q2
2025
Jun 30, 2025
($701.0K)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($701.0K)
Nov 19, 2025
Q1
2025
Mar 31, 2025
($1.05M)
May 15, 2025
Q2
2025
Mar 31, 2025
($1.05M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($1.05M)
Nov 19, 2025
Q3
2025
Sep 30, 2024
($1.97M)
Nov 19, 2025
Q2
2025
Jun 30, 2024
($1.54M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($1.54M)
Nov 19, 2025
Q3
2025
Mar 31, 2024
($1.39M)
Nov 19, 2025
Q1
2025
Mar 31, 2024
($1.39M)
May 15, 2025
Q2
2025
Mar 31, 2024
($1.39M)
Aug 14, 2025
Q3
2024
Sep 30, 2023
($174.9K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.00M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($1.00M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
$1.45M
May 15, 2024
Q3
2024
Mar 31, 2023
$1.45M
Nov 14, 2024
Q2
2024
Mar 31, 2023
$1.45M
Aug 14, 2024
Q3
2023
Sep 30, 2022
($1.78M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.59M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($529.6K)
Nov 19, 2025
Q2
2025
Jun 30, 2025
($435.4K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($617.4K)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.67M)
Nov 19, 2025
Q2
2025
Jun 30, 2024
($1.08M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.18M)
May 15, 2025
Q3
2024
Sep 30, 2023
($1.18M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($798.1K)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.06M)
May 15, 2024
Q3
2023
Sep 30, 2022
($1.53M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($1.53M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($1.45M)
May 15, 2023
Q3
2022
Sep 30, 2021
($490.3K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.41M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.57M)
May 16, 2022
Q3
2021
Sep 30, 2020
($843.1K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($650.0K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($527.6K)
May 17, 2021
Q3
2020
Sep 30, 2019
($815.7K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($698.2K)
Aug 14, 2020